• 1
    Charlesworth EN, Hood AF, Soter NA, Kagey Sobotka A, Norman PS, Lichtenstein LM. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989;83:15191526.
  • 2
    Iliopoulos O, Baroody FM, Naclerio RM, Bochner BS, Kagey Sobotka A, Lichtenstein LM. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 1992;148:22232228.
  • 3
    White MV, Igarashi Y, Emery BE, Lotze MT, Kaliner MA. Effects of in vivo administration of interleukin-2 (IL-2) and IL- 4, alone and in combination, on ex vivo human basophil histamine release. Blood 1992;79:14911495.
  • 4
    Hirai K, Morita Y, Misaki Y, et al. Modulation of human basophil histamine release by hemopoietic growth factors. J Immunol 1988;141:39583964.
  • 5
    Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993;177:605611.
  • 6
    Kurimoto Y, De Weck AL, Dahinden CA. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation. Eur J Immunol 1991;21:361368.
  • 7
    Miadonna A, Roncarolo MG, Lorini M, Tedeschi A. Inducing and enhancing effects of IL-3, -5, and -6 and GM-CSF on histamine release from human basophils. Clin Immunol Immunopathol 1993;67:210215.DOI: 10.1006/clin.1993.1067
  • 8
    Lopez AF, Eglinton JM, Lyons AB, et al. Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity. J Cell Physiol 1990;145:6977.
  • 9
    MacGlashan DWJ. Signal transduction and cytokine production by human basophils. Chem Immunol 1995;61:88113.
  • 10
    MacGlashan DJ, Botana LM. Biphasic Ca2+ responses in human basophils. Evidence that the initial transient elevation associated with the mobilization of intracellular calcium is an insufficient signal for degranulation. J Immunol 1993;150:980991.
  • 11
    Camacho P, Lechleiter JD. Calreticulin inhibits repetitive intracellular Ca2+ waves. Cell 1995;82:765771.
  • 12
    Bjerke T, Nielsen S, Helgestad J, Nielsen BW, Schiøtz PO. Purification of human blood basophils by negative selection using immunomagnetic beads. J Immunol Methods 1993;157:4956.
  • 13
    Skov PS, Norn S, Weeke B. Histamine release and pathological states. A new method for measuring histamine release. Agents Actions 1984;14:414416.
  • 14
    Celis JE, Ratz G, Basse B, Lauridsen JB, Celis A. High-resolution two-dimensional gel electrophoresis of proteins: isoelectric focusing and nonequilibrium pH gradient electrophoresis. In: CelisJE, editor. Cell biology. A laboratory handbook. London: Academic Press, 1994: 222230.
  • 15
    Hoffman HJ, Celis JE. Calcium overlay assay. In: CelisJE, editor. Cell biology. A laboratory handbook. London: Academic Press, 1994:309312.
  • 16
    Wilm M, Shevchenko A, Houthaeve T, et al. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 1996;379:466469.
  • 17
    Appel RD, Bairoch A, Hochstrasser DF. A new generation of information retrieval tools for biologists: the example of the ExPASy WWW server. Trends Biochem Sci 1994;19:258260.
  • 18
    Nielsen HV, Johnsen A, Sanchez J-S, Hochstrasser DF, Schiøtz PO. Identification of a basophil IL-3 regulated protein that is identical to IgE dependent histamine releasing factor. Allergy 1998;53:642652.
  • 19
    Denning GM, Leidal KG, Holst VA, et al. Calreticulin biosynthesis and processing in human myeloid cells: demonstration of signal peptide cleavage and N-glycosylation. Blood 1997;90:372381.
  • 20
    Nielsen HV, Shah PM, Schiøtz PO. Factors determining spontaneous histamine release from human basophils purified with Percoll gradients and Dynabeads. Allergy 1998;53:302306.
  • 21
    MacGlashan DJ, Warner J. Stimulus-dependent leukotriene release from human basophils: a comparative study of C5a and Fmet-leu-phe. J Leukoc Biol 1991;49:2940.
  • 22
    MacGlashan DWJ, Hubbard WC. IL-3 alters free arachidonic acid generation in C5a-stimulated human basophils. J Immunol 1993;151:63586369.
  • 23
    Yamaguchi M, Hirai K, Ohta K, et al. Nonreleasing basophils convert to releasing basophils by culturing with IL-3. J Allergy Clin Immunol 1996;97:12791287.
  • 24
    Nguyen KL, Gillis S, MacGlashan DWJ. A comparative study of releasing and nonreleasing human basophils: nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking. J Allergy Clin Immunol 1990;85:10201029.
  • 25
    Bastianutto C, Clementi E, Codazzi F, et al. Overexpression of calreticulin increases the Ca2+ capacity of rapidly exchanging Ca2+ stores and reveals aspects of their lumenal microenvironment and function. J Cell Biol 1995;130:847855.
  • 26
    Mery L, Mesaeli N, Michalak M, Opas M, Lew DP, Krause KH. Overexpression of calreticulin increases intracellular Ca2+ storage and decreases store-operated Ca2+ influx. J Biol Chem 1996;271:93329339.
  • 27
    Michalak M, Burns K, Andrin C, et al. Endoplasmic reticulum form of calreticulin modulates glucocorticoid-sensitive gene expression. J Biol Chem 1996;271:2943629445.
  • 28
    Vanlingen S, Parys JB, Missiaen L, De Smedt H, Wuytack F, Casteels R. Distribution of inositol 1,4,5-trisphosphate receptor isoforms, SERCA isoforms and Ca2+ binding proteins in RBL-2H3 rat basophilic leukemia cells. Cell Calcium 1997;22:475486.
  • 29
    Mesaeli N, Nakamura K, Zvaritch E, et al. Calreticulin is essential for cardiac development. J Cell Biol 1999;144:857868.
  • 30
    Liu N, Fine RE, Simons E, Johnson RJ. Decreasing calreticulin expression lowers the Ca2+ response to bradykinin and increases sensitivity to ionomycin in NG-108–15 cells. J Biol Chem 1994;269:2863528639.
  • 31
    Coppolino MG, Woodside MJ, Demaurex N, Grinstein S, St Arnaud R, Dedhar S. Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. Nature 1997;386:843847.
  • 32
    Wheeler DG, Horsford J, Michalak M, White JH, Hendy GN. Calreticulin inhibits vitamin D3 signal transduction. Nucleic Acids Res 1995;23:32683274.
  • 33
    Burns K, Duggan B, Atkinson EA, et al. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 1994;367:476480.
  • 34
    Shago M, Flock G, Leung Hagesteijn CY, et al. Modulation of the retinoic acid and retinoid X receptor signaling pathways in P19 embryonal carcinoma cells by calreticulin. Exp Cell Res 1997;230:5060.DOI: 10.1006/excr.1996.3408
  • 35
    Dedhar S, Rennie PS, Shago M, et al. Inhibition of nuclear hormone receptor activity by calreticulin. Nature 1994;367:480483.
  • 36
    Schleimer RP, Derse CP, Friedman B, et al. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol 1989;143:13101317.